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Abstract
Background: In resource-limited nations like Nepal, congenital defects, including neural tube defects (NTDs), have great
public health impact. NTDs and a few other congenital defects can be prevented by micronutrient supplementation.
Without proper research regarding such defects, it is difficult to assess the damage made to health and productivity. This
study aims to investigate different congenital defects among children in Nepal.
Methods: Household surveys and health camps were conducted from 2011 to 2012. Physical examination of women of
reproductive age (15 to 49 years) was done in selected Village Development Committees of nine districts in three
ecological regions of Nepal. Congenital defects, including NTDs, were examined in children (age 0 to 5 years) who were
alive at the time of the survey. Data entry and analysis was performed by using SPSS version 11.5.
Results: 21,111 women were interviewed and 27,201 children born to them were assessed. The prevalence of congenital
defects was 52.0 (95 % CI: 44.0–61.0) per 10,000 children. The prevalence of selected NTDs was 4.0 (95 % CI: 2.0–7.0) per
10,000 children. Among the neural tube defects, encephalocele, myelomeningocele and dermal sinus were the major
ones, having almost the same prevalence in the Hill and Terai regions. The majority of children with genital abnormalities
(17.0 per 10,000 children; 95 % CI: 10.0–28.0) and limb deformities (14.0 per 10,000 children; 95 % CI: 8.0–24.0) were found
in the Terai. The rate of congenital birth defects was higher in the regions where women were in poor health.
Conclusion: There is high prevalence of congenital defects in Nepal. Since such defects add a burden to families and
society, it is imperative that health policies addressing programs like supplementation, fortification and dietary
diversification be implemented.
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Background
Congenital defects (birth defects) are structural or
functional anomalies, which are present at the time of
birth. Globally, congenital defects affect an estimated 1 in
33 infants and result in approximately 3.2 million birth
defect-related disabilities every year [1]. Congenital defects
may result in long-term disability, which may have signifi-
cant impacts on individuals, families, health-care systems
and societies. Although congenital defects may be gen-
etic, infectious or environmental in origin, many can
be prevented. One of the most severe defects that can
be prevented is neural tube defects (NTDs). NTDs are
serious birth defects of the brain and spine, which can
be prevented by the supply of folic acid before and
during pregnancy [2]. They happen very early in preg-
nancy when the neural tube, which becomes the brain and
the spine, does not close properly, and they are a major
cause of death and lifelong disability. Each year more than
300,000 babies are born with neural tube defects
worldwide [3] of which almost 70 % are from low- and
middle-resource countries. Increasing folic acid intake
among women of reproductive age can help prevent
these defects [4]. Even in developed nations like the
United States, 3000 pregnancies are affected by NTDs
every year [5]. The total lifetime direct cost of care for
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a child born with NTDs is very high as shown by a
study in United States [6].
In Nepal, there is limited information regarding the
prevalence of congenital defects including NTDs. Without
proper research regarding such defects, it is difficult to
assess the damage made to health and productivity. There-
fore, the aim of this study was to determine the prevalence
of congenital defects and selected NTDs in Nepal.
Methods
Study area
Nepal is divided into three distinct ecological regions:
Mountain, Hill and Terai. The Mountain region has rocky
terrain and lies to the north. It has only about 7 % of the
total population. In the middle lies the Hill region, which
occupies 42 % of the total land area. About 43 % of the
total population lives in the Hill region. The Terai region
lies in the southern part of the country and has flat terrain.
While it constitutes only 23 % of the total land area in
Nepal, 50 % of the population live here. Each region is
subdivided into districts and within the districts are
Village Development Committees (VDCs). In consult-
ation with the Nepal Ministry of Health and Population,
and according to feasibility of the research work, nine dis-
tricts (Dolakha-Mountain; Illam, Kavrepalanchowk, Kath
mandu, Lamjung and Kaski-Hill; Sarlahi, Nawalparasi and
Kailali-Terai) covering three ecological regions of Nepal
were included. From nine districts, four to eight VDCs
were selected in consultation with District Public/Health
Offices.
Study population
Children aged 0 to 5 years who were alive at the time of
the survey and their mothers residing in the selected
geographical areas were included in the study.
Study design and health camp
Both household surveys and health research camps
were conducted from 2011 to 2012. Interviews of
reproductive age women were done in the household
survey using structured questionnaires and pictures of
different types of defects. The women were invited to
attend a health camp by the field supervisor at the
time of survey. The health camps were conducted in
the health facilities of the concerned VDCs for clinical
assessment. A qualified doctor conducted physical
examinations of women and children. If the mothers
were not able to bring their children for some reason,
they were shown pictures of malformations and asked
to indicate if their child had those malformations.
Nurse and health facility staffs were involved in the
assessment of women, which included measuring
height, weight, and blood pressure. After the physical
examination, capillary blood samples were tested for
hematocrit determination by a laboratory technician with
a hematocrit machine (Heamata STAT-II, STI Separation
Technology Inc., USA). A structured nutrition education
program was also conducted, highlighting the requirement
of micronutrients for reproductive aged women specific-
ally for the prevention of NTDs and other birth defects.
Sample size
This study is a part of an intervention study where repro-
ductive age women were supplied multivitamin-minerals
for one year. The study was primarily designed to test
model of distribution of multivitamin-minerals and to test
the education module. Altogether 21,371 women were
enrolled in the survey. However, only 21,111 women partic-
ipated in both the survey and health camps. A total of
27,201 children (3079 in Mountain, 15,156 in Hill and
8966 in Terai) born within the past five years before the
study period were included in the study. Not all women
were included in the study because of the exclusion of
missing values (n = 6), absence of women in the health
camps (n = 214) and incomplete information from some
(n = 40).
Ethical approval
Ethical clearance was taken from the Ethical Committee
of the Nepal Health Research Council (NHRC reg. no.
5/2011) as per national health research policy. Written
consent was obtained from the Ministry of Health and
Population and District Public/Health Offices from targeted
districts. Written and oral informed consent was taken
from the participant women. In addition, written consent
from parents/guardians was taken in case of participants
under 18 years of age.
Anthropometric measurements
Weights of the women were measured to the nearest
0.1 kg on a battery powered digital scale (Seca GmBH
& Co.kg., Germany) and heights were measured to the
nearest centimeter using a height scale following standard
anthropometric techniques [7]. For weight and height
measurements, study subjects removed their shoes and
jackets and wore light clothing. Body mass index (BMI) of
the study subjects was calculated by dividing the weight in
kilograms by the height in meter squared (kg/m2). A BMI
less than 18.5 was considered as underweight [8]. Anemia
was defined as a hematocrit value less than 35 % and nor-
mal as more than 35 % [9].
Data analysis
Data entry and analysis was performed by using SPSS for
windows version 11.5 (SPSS Inc.). Descriptive analysis was
done and the result was expressed in percentage, ratio and
rate. The lower and upper limits of the 95 % confidence
interval (CI) for a proportion were calculated.
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Operational definitions
Prevalence: The presence of any congenital defects in
children (numerator) in the total population of children
(0 to 5 years of age) per 10,000 children (denominator).
NTD: Any one of these defects: anencephaly, spina
bifida (myelomeningocele and meningocele),
encephalocele, dermal sinus and caudal agenesis.
Cleft palate: An opening in the roof of the mouth due
to a failure of the palatal shelves to come fully together
from either side of the mouth.
Cleft lip: A fissure in the upper lip that is due to failure
of the left and right sides of the fetal lip tissue to fuse.
Limb deformities: Any structural or functional damage
of the hands or legs at birth.
Genital abnormalities: Any physical abnormality of the
male or female internal or external genitalia present at
birth.
Any other deformities: Any type of deformities other
than mentioned above (for example, outgrowth of skin
mass from head scalp).
Results
The prevalence of congenital defects was 52.0 per 10,000
children while the prevalence of selected NTDs was 4.0
per 10,000 children. The prevalence of congenital defects
was higher (58.0 per 10,000 children) in the Terai region
(Table 1).
Among the neural tube defects, encephalocele, myelome-
ningocele and dermal sinus were the ones having almost
the same prevalence in the Hill and Terai regions. However,
in the Mountain region no such defects were recorded
(Table 2).
The majority of children with genital abnormalities
(17.0 per 10,000 children) and limb deformities (14.0 per
10,000 children) were found higher in the Terai. Any other
deformities were found higher (21.0 per 10,000 children)
in the hilly districts (Table 3).
The rate of congenital birth defects was higher in the
regions where there was poor health status of women as
indicated by low BMI and high anemia rate. However,
there was no such relation in the regions with women with
hypertension (Table 4).
Discussion
The present study showed a prevalence of selected NTDs
of 4.0 per 10,000 children. The prevalence is underesti-
mated since these results did not include those children
who might have died due to NTDs, the majority with
anencephaly. In addition, the results were obtained from
the women and children who participated in the survey
and health camps. The present result is far less than the
status of NTDs in India, 17.0 per 10,000 births [10]. This
is most likely due to the inclusion of anencephaly cases in
the study of India but not in the present study. However,
in developed nations like the USA, the estimates are below
3.0 per 10,000 births [11] and in Australia below 5.0 per
10,000 births [12]. Even in a study done in Iran, the preva-
lence of NTDs is below 10.0 per 10,000 live births [13].
The reduction in the frequency of NTDs is mainly due to
the supplementation of folic acid before pregnancy, which
is still lacking in Nepal. Although the government of Nepal
supplies free iron and folic acid to pregnant women after
the first trimester [14], it is very late, as the formation of
the neural tube begins from the 28th day after conception.
In addition, most of the pregnancies in Nepal are un-
planned and are noticed only a month or two after con-
ception. Therefore, there is a need to review the policy.
All women of childbearing age should get free iron/folic
acid by either supplementation or fortification through-
out their reproductive age.
The congenital defects in the present study varied with
the ecological regions: the highest prevalence being in
the Terai. Although genetic and environmental factors can
cause congenital anomalies [15], poor nutrition can also be
one of the most important causative factors. Studies have
shown that some of the defects due to lack of proper
nutrition can be prevented, thereby saving many lives
[16, 17]. An important part of a nutrition program is
folic acid supplementation, which can prevent birth
defects [18]. In addition, periconception folic acid or
folic acid-containing multivitamin supplementation has
resulted in a breakthrough in the primary prevention of
neural-tube defects, cardiovascular abnormalities and
other defects [19].
The prevalence of encephalocele, myelomeningocele and
dermal sinus are higher in the Terai region. These defects
can mostly be prevented by the proper supplementation of
folic acid or fortification of food items with folic acid [16].
In addition, education regarding the benefits of taking folic
Table 1 Prevalence of neural tube and other birth defects
Indicators Prevalence per 10,000
(n/N)*
95 %
CI
Prevalence of congenital defects 52.0 (142/27201) 44.0–
61.0
Prevalence of selected NTDs only 4.0 (11/27201) 2.0–7.0
Prevalence of other congenital defects
except NTDs
48.0 (131/27201) 40.0–
57.0
Prevalence of congenital defects in
Mountain
16.0 (5/3079) 7.0–
38.0
Prevalence of congenital defects in Hill 56.0 (85/15156) 45.0–
69.0
Prevalence of congenital defects in
Terai
58.0 (52/8966) 44.0–
76.0
Abbreviations: CI confidence interval
* n denotes the children with congenital defects and N denotes total
live children
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acid can play an important role [20]. Since very few
women were enrolled in the Mountain area, there was
no prevalence of NTDs noted. Although there seems to
be an absence of NTDs in the Mountain area, we
should still provide folic acid supplementation in order
to prevent such defects.
This study showed that the overall prevalence of
congenital defects was 52.0 per 10,000 children. This
is higher than the prevalence of congenital anomalies
(27.0 per 10,000 live births) in a study done in the
northwest of Iran [13]. Even in developed nations, the
prevalence of congenital anomalies is very high- up to
239.0 per 10,000 births [21]. The prevalence of genital
abnormalities (17.0 per 10,000 children) and limb deform-
ities (15.0 per 10,000 children) were higher in the Terai in
Nepal. There are several causes of congenital defects, the
most important being environmental and genetic factors
[15], poor nutritional status of mothers, improper drug use
during pregnancy, and alcohol use during pregnancy [22].
In addition, lack of proper knowledge regarding prenatal
care in mothers can contribute to congenital defects.
Therefore, control of environmental risk factors is a crucial
policy priority for the primary prevention of congenital
defects in the population, including preconception care
and whole population approaches.
The present study showed that in the regions where there
is poor nutritional health status as shown by low BMI, there
was a high number of congenital defects at birth. This
implies that poor nutrition can also have a great impact on
health [23], making more children disabled and even taking
their lives [24]. Consequently, it can add a significant
burden to the national economy. The government should
be judicious in its plans and actions to reduce under
nutrition.
Although the study showed the prevalence of congenital
defects in Nepal, it has some limitations. First, detection
of birth defects was limited to the most obvious ones that
were shown to women through pictures. This would lead
to an undercounting of other defects. The NTD preva-
lence obtained in this survey in Nepal is low for a number
of reasons. The current survey failed to capture anenceph-
alic cases that are stillborn or die shortly after birth, and
anencephaly may account for half of all NTDs. Prevalence
at birth could not be determined as this study was a
cross-sectional study of children aged 0 to 5 years that
were alive at the time of the survey. Therefore, our
prevalence estimates would underestimate the birth
prevalence, particularly for defects that are associated
with shorter periods of survival. Pregnancy outcomes
such as spontaneous abortions, fetal deaths and elect-
ive terminations impact the overall rate of NTDs.
Finally, use of unwanted drugs, alcohol and other en-
vironmental effects that can lead to birth defects were
not considered.
Conclusion
The prevalence of selected NTDs and other congenital
defects is high in Nepal. However, some of these defects
can be prevented through proper nutrition and either
supplementation or fortification of women’s diets with
folic acid. It is the responsibility of all concerned people
and organizations to rectify this situation.
Table 2 Type of neural tube defects
Neural tube
defects
Hill 95 %
CI
Terai 95 % CI
n(prevalence per 10,000) n(prevalence per 10,000)
Encephalocele 4 (3.0) 1.0–7.0 4 (4.0) 1.0–11.0
Myelomeningocele 1 (1.0) 0.0–4.0 1 (1.0) 0.0–6.0
Dermal sinus 0 (0.0) – 1 (1.0) 0.0–6.0
Abbreviations: CI confidence interval
Table 3 Type of other congenital defects except NTDs
Birth defects Mountain
n(prevalence
per 10,000)
95 % CI Hill 95 % CI Terai 95 % CI
n(prevalence per 10,000) n(prevalence per 10,000)
Hydrocephalus 0 (0.0) – 8 (5.0) 2.0–10.0 8 (9.0) 5.0–18.0
Scoliosis 0 (0.0) – 1 (1.0) 0.0–4.0 1 (1.0) 0.0–6.0
Cleft palate 2 (6.0) 2.0–23.0 7 (5.0) 2.0–10.0 4 (4.0) 1.0–11.0
Cleft lip 0 (0.0) – 3 (2.0) 1.0–6.0 1 (1.0) 0.0–6.0
Limb deformities 0 (0.0) – 19 (13.0) 8.0–20.0 13 (14.0) 8.0–24.0
Genital abnormalities 0 (0.0) – 11 (7.0) 4.0–13.0 15 (17.0) 10.0–28.0
Any other deformities 3 (10.0) 3.0–29.0 31 (21.0) 14.0–28.0 4 (4.0) 1.0–11.0
Abbreviations: CI confidence interval
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Table 4 Ecological relations of congenital defects with general
health of women
Ecological
regions
Anemia,
n (%)
Underweight
BMI, n (%)
Hypertension,
n (%)
Congenital
defects per
10,000
Mountain 20 (2.2) 54 (6.1) 85 (9.4) 16.0
Hill 2165
(26.0)
1161 (14.8) 432 (5.2) 56.0
Terai 1232
(24.7)
1235 (26.6) 431 (8.6) 58.0
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